T. Rowe Price Investment Management, Inc. Cabaletta Bio, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $151 Billion
- Q1 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 3,970,026 shares of CABA stock, worth $5.56 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,970,026
Previous 4,074,006
2.55%
Holding current value
$5.56 Million
Previous $9.25 Million
40.54%
% of portfolio
0.0%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding CABA
# of Institutions
92Shares Held
39.9MCall Options Held
154KPut Options Held
192K-
Jennison Associates LLC6.02MShares$8.43 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.76MShares$6.66 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$5.09 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.84MShares$3.98 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.76MShares$3.87 Million1.29% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $40.6M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...